{"paper_id": "0cce523137d8be40931f2c2a72b0ce3b84fb4ba0", "metadata": {"title": "Case Series of the Month 3 Clinical Course, Imaging Features, and Outcomes of COVID-19 4 in Kidney Transplant Recipients Article info", "authors": [{"first": "M", "middle": ["E"], "last": "", "suffix": "", "affiliation": {}, "email": ""}, {"first": "James", "middle": [], "last": "Catto", "suffix": "", "affiliation": {"laboratory": "", "institution": "Shahid Beheshti University of Medical Sciences", "location": {"settlement": "Tehran", "country": "Iran"}}, "email": ""}]}, "abstract": [], "body_text": [{"text": "Case series 13 1.1. Background 14 On December 31, 2019, a nov Q7 el corona virus was extracted 15 from the respiratory secretions of several patients present- 16 ing with lower respiratory tract infection of unknown origin 17 in Wuhan, China [1] . While the mortality rate of coronavirus 18 disease 2019 (COVID-19) is believed to be approximately 5% 19 [2] , older adults and those with an underlying chronic 20 disease are specifically at high risk of presenting with severe 21 symptoms, having poorer prognosis, and even developing 22 fatal conditions [3] . Use of immunosuppressive medications 23 such as steroids may also be linked to severe manifestation E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X a v a i l a b l e a t w w w . s c i e n c e d i r e c t . c o m j o u r n a l h o m e p a g e : w w w . e u r o p e a n u r o l o g y . c o m of the disease, as in patients with previous respiratory viral 25 infections such as H1N1 [4] . 26 Solid organ transplant recipients are on long-term 27 immunosuppressive regimens and are at particular risk of 28 contracting severe respiratory tract infection and possibly 29 with atypical presentation [5] . (Table 4) . 122 We did not observe cavitation, cystic changes, or progressive radiologic changes such as bilateral areas of air 136 space opacity (Fig. 2) .", "cite_spans": [{"start": 12, "end": 14, "text": "13", "ref_id": "BIBREF17"}, {"start": 31, "end": 33, "text": "14", "ref_id": "BIBREF18"}, {"start": 95, "end": 97, "text": "15", "ref_id": "BIBREF20"}, {"start": 159, "end": 161, "text": "16", "ref_id": "BIBREF23"}, {"start": 223, "end": 225, "text": "17", "ref_id": "BIBREF24"}, {"start": 242, "end": 245, "text": "[1]", "ref_id": "BIBREF0"}, {"start": 353, "end": 356, "text": "[2]", "ref_id": "BIBREF1"}, {"start": 554, "end": 557, "text": "[3]", "ref_id": "BIBREF2"}, {"start": 597, "end": 599, "text": "23", "ref_id": null}, {"start": 926, "end": 928, "text": "25", "ref_id": null}, {"start": 953, "end": 956, "text": "[4]", "ref_id": "BIBREF4"}, {"start": 959, "end": 961, "text": "26", "ref_id": null}, {"start": 1013, "end": 1015, "text": "27", "ref_id": null}, {"start": 1073, "end": 1075, "text": "28", "ref_id": null}, {"start": 1166, "end": 1169, "text": "[5]", "ref_id": "BIBREF5"}, {"start": 1184, "end": 1187, "text": "122", "ref_id": null}], "ref_spans": [{"start": 1172, "end": 1181, "text": "(Table 4)", "ref_id": "TABREF5"}, {"start": 1318, "end": 1326, "text": "(Fig. 2)", "ref_id": "FIGREF5"}], "section": "1."}, {"text": "Of the 12 patients, ten were admitted to an intensive care another study [13] . In contrast to our results, Fishman and", "cite_spans": [{"start": 73, "end": 77, "text": "[13]", "ref_id": "BIBREF17"}], "ref_spans": [], "section": "137"}, {"text": "Grossi [14] reported that leukopenia and lymphopenia were E U R O P E A N U R O L O G Y X X X ( 2 0 1 9 ) X X X -X X X involvement and subsegmental consolidation [17] .", "cite_spans": [{"start": 7, "end": 11, "text": "[14]", "ref_id": "BIBREF18"}, {"start": 162, "end": 166, "text": "[17]", "ref_id": "BIBREF24"}], "ref_spans": [], "section": "172"}, {"text": "Our study revealed that interlobular septal thickening, ", "cite_spans": [], "ref_spans": [], "section": "172"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Clinical features of patients infected 220 with 2019 novel coronavirus in Wuhan, China", "authors": [{"first": "C", "middle": [], "last": "Huang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Wang", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}], "year": 2020, "venue": "Lancet", "volume": "395", "issn": "", "pages": "497--506", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "Understanding of COVID-19 based on 221 current evidence", "authors": [{"first": "P", "middle": [], "last": "Sun", "suffix": ""}, {"first": "X", "middle": [], "last": "Lu", "suffix": ""}, {"first": "C", "middle": [], "last": "Xu", "suffix": ""}, {"first": "W", "middle": [], "last": "Sun", "suffix": ""}, {"first": "B", "middle": [], "last": "Pan", "suffix": ""}], "year": 2020, "venue": "J Med Virol", "volume": "92", "issn": "", "pages": "548--51", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Epidemiological and clinical char-222", "authors": [{"first": "N", "middle": [], "last": "Chen", "suffix": ""}, {"first": "M", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "X", "middle": [], "last": "Dong", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "China: a descriptive study", "authors": [{"first": "", "middle": [], "last": "Wuhan", "suffix": ""}], "year": 2020, "venue": "Lancet", "volume": "395", "issn": "", "pages": "507--520", "other_ids": {}}, "BIBREF4": {"ref_id": "b4", "title": "Immunosuppressed patients 224 with pandemic influenza A 2009 (H1N1) virus infection", "authors": [{"first": "E", "middle": [], "last": "Cordero", "suffix": ""}, {"first": "T", "middle": [], "last": "Aydillo", "suffix": ""}, {"first": "M", "middle": [], "last": "Farinas", "suffix": ""}], "year": 2012, "venue": "Eur J Clin Microbiol Infect Dis", "volume": "31", "issn": "", "pages": "547--56", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "Respiratory tract infections in the immunocom-225 promised", "authors": [{"first": "G", "middle": [], "last": "Godbole", "suffix": ""}, {"first": "V", "middle": [], "last": "Gant", "suffix": ""}], "year": 2013, "venue": "Curr Opin Pulmon Med", "volume": "19", "issn": "", "pages": "244--50", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "The 226 facts during the third epidemic. Liver Transpl", "authors": [{"first": "L", "middle": [], "last": "D&apos;antiga", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1002/lt.25756"]}}, "BIBREF7": {"ref_id": "b7", "title": "SARS-CoV-2: virus dynamics and host response", "authors": [{"first": "Y", "middle": [], "last": "Chen", "suffix": ""}, {"first": "L", "middle": [], "last": "Li", "suffix": ""}], "year": null, "venue": "Lancet", "volume": "228", "issn": "", "pages": "", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "CT image visual quantitative evaluation and 230", "authors": [{"first": "K", "middle": [], "last": "Li", "suffix": ""}, {"first": "Y", "middle": [], "last": "Fang", "suffix": ""}, {"first": "W", "middle": [], "last": "Li", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "clinical classification of coronavirus disease (COVID-19)", "authors": [], "year": null, "venue": "Eur Radiol", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "Epidemiological and 232 clinical aspects of COVID-19; a narrative review", "authors": [{"first": "G", "middle": [], "last": "Kolifarhood", "suffix": ""}, {"first": "M", "middle": [], "last": "Aghaali", "suffix": ""}, {"first": "H", "middle": ["M"], "last": "Saadati", "suffix": ""}], "year": 2020, "venue": "Arch Acad Emerg Med", "volume": "8", "issn": "", "pages": "", "other_ids": {}}, "BIBREF13": {"ref_id": "b13", "title": "COVID-19 in a kidney 234 transplant patient", "authors": [{"first": "J", "middle": [], "last": "Wang", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}, {"first": "G", "middle": [], "last": "Cao", "suffix": ""}, {"first": "X", "middle": [], "last": "Wu", "suffix": ""}, {"first": "Z", "middle": [], "last": "Wang", "suffix": ""}, {"first": "T", "middle": [], "last": "Yan", "suffix": ""}], "year": null, "venue": "Eur Urol. In press", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/j.eururo.2020.03.036"]}}, "BIBREF14": {"ref_id": "b14", "title": "Case report of COVID-19 in a 237 kidney transplant recipient: does immunosuppression alter the 238 clinical presentation?", "authors": [{"first": "E", "middle": [], "last": "Guillen", "suffix": ""}, {"first": "G", "middle": ["J"], "last": "Pineiro", "suffix": ""}, {"first": "I", "middle": [], "last": "Revuelta", "suffix": ""}], "year": null, "venue": "Am J Transpl", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1111/ajt.15874"]}}, "BIBREF15": {"ref_id": "b15", "title": "Clinical characteristics of 138 hospitalized 241 patients with 2019 novel coronavirus", "authors": [{"first": "D", "middle": [], "last": "Wang", "suffix": ""}, {"first": "B", "middle": [], "last": "Hu", "suffix": ""}, {"first": "C", "middle": [], "last": "Hu", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF17": {"ref_id": "b17", "title": "Identification of kidney transplant 244 recipients with coronavirus disease 2019", "authors": [{"first": "H", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Chen", "suffix": ""}, {"first": "Q", "middle": [], "last": "Yuan", "suffix": ""}], "year": null, "venue": "Eur Urol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/j.eururo.2020.03.030"]}}, "BIBREF18": {"ref_id": "b18", "title": "Novel coronavirus-19 (COVID-19) in the 247 immunocompromised transplant recipient: #flatteningthecurve", "authors": [{"first": "J", "middle": ["A"], "last": "Fishman", "suffix": ""}, {"first": "P", "middle": ["A"], "last": "Grossi", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF19": {"ref_id": "b19", "title": "press", "authors": [{"first": "J", "middle": [], "last": "Am", "suffix": ""}, {"first": "", "middle": [], "last": "Transpl", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1111/ajt.15890"]}}, "BIBREF20": {"ref_id": "b20", "title": "Successful recovery of COVID-19 pneumonia 250", "authors": [{"first": "L", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "X", "middle": [], "last": "Xu", "suffix": ""}, {"first": "K", "middle": [], "last": "Ma", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF21": {"ref_id": "b21", "title": "in a renal transplant recipient with long-term immunosuppression", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF22": {"ref_id": "b22", "title": "press", "authors": [{"first": "J", "middle": [], "last": "Am", "suffix": ""}, {"first": "", "middle": [], "last": "Transpl", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1111/ajt.15869"]}}, "BIBREF23": {"ref_id": "b23", "title": "Relation between chest CT findings 253 and clinical condit Q10 ions of coronavirus disease (COVID-19) pneumo-254 nia: a multicenter study", "authors": [{"first": "W", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "Z", "middle": [], "last": "Zhong", "suffix": ""}, {"first": "X", "middle": [], "last": "Xie", "suffix": ""}, {"first": "Q", "middle": [], "last": "Yu", "suffix": ""}, {"first": "J", "middle": [], "last": "Liu", "suffix": ""}], "year": 2020, "venue": "Am J Roentgenol", "volume": "214", "issn": "255", "pages": "1072--1079", "other_ids": {}}, "BIBREF24": {"ref_id": "b24", "title": "Coronavirus 256 disease 2019 (COVID-19): a systematic review of imaging", "authors": [{"first": "S", "middle": [], "last": "Salehi", "suffix": ""}, {"first": "A", "middle": [], "last": "Abedi", "suffix": ""}, {"first": "S", "middle": [], "last": "Balakrishnan", "suffix": ""}, {"first": "A", "middle": [], "last": "Gholamrezanezhad", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "in the case of hypoxemia and a creatinine 84 rise with clinical suspicion of kidney transplant rejection. 85 As a part of our national COVID-19 guidelines, all patients 86 underwent noncontrast chest CT imaging using a low-dose 87 protocol. Two expert radiologists with 9 and 18 yr of 88 experience interpreted the images independently. In the 89 case of disagreement between the readings, the two 90 radiologists reassessed the images in order to reach 91 consensus. The laterality of the disease (unilateral vs 92 bilateral), the distribution (peripheral vs central, anterior 93 vs posterior), and the predominant zonal involvement 94 (upper, middle, lower, or diffuse) were recorded. The 95 predominant pattern of involvement in each lobe was 96 assessed and categorized as ground-glass opacity (GGO) or 97 consolidation. When there was a combination of GGO and 98 consolidation, the allocation was divided between them 99 accordingly. The percentage of lobar involvement was 100 scored using the following system: 0, no involvement; 1, 101 <25%; 2, 26-50%; 3, 51-75%; and 4, >75% involvement 102 [8]. The scores for each lobe were summed to calculate the 103 total lung score (maximum score 20). The final score was 104 multiplied by five to estimate the percentage lung involve-105 ment. The presence of other imaging features was also", "latex": null, "type": "figure"}, "FIGREF1": {"text": "The initial CT scan on admission showed bilateral lung112 involvement in eight patients and unilateral involvement in 113 four. The lower lobes were frequently involved, as observed 114 in 11/12 of patients (Table 3). A combination of consolida-115 tion and GGO was the most predominant (75%) pattern, 116 followed by GGO only (25%; Fig. 1). In terms of lesion 117 distribution, a combination of peripheral plus central 118 involvement was the most common. The mean lung 119 involvement score was 9.5 AE 5.5 out of 20, which gives a 120 mean estimate of 47.5 AE 27.8% for total lung involvement121", "latex": null, "type": "figure"}, "FIGREF2": {"text": "lymphadenopathy in any of the study population. Three124 patients had pleural or pericardial effusion or both. Four 125 patients had a mildly elevated cardiothoracic ratio on chest 126 CT. Pneumomediastinum was observed in two patients who 127 had severe changes on chest CT, but neither was intubated 128 or underwent noninvasive ventilation (NIV) before acquisi-129 tion of the CT scan.", "latex": null, "type": "figure"}, "FIGREF3": {"text": "unit, nine were intubated, eight died of severe COVID-19 139 pneumonia and acute respiratory distress syndrome 140 (ARDS), and four were discharged after complete recovery. 141 Three patients required neither NIV nor intubation. The 142 median hospital stay was 15 d (interquartile range [IQR]143 8.0-21.5), with a longer stay for patients who died (18.to long-term immunosuppressive therapy, kidney 149 transplant recipients are at higher risk of COVID-19 150 involvement in comparison to immunocompetent individ-151 uals. However, a few studies with small sample sizes have 152 reported conflicting results for the characteristics of COVID-153 19 in these patients. In solid organ transplant recipients, the 154 clinical presentation, imaging findings, laboratory data, and 155 outcomes may differ from those for other adults and vary 156 among patients. 157 On initial presentation, just one of our 12 cases had 158 gastrointestinal symptoms; the most typical presentation 159 was cough and fever, as for other adults [9,10]. Guillen et al 160 [11] reported on a patient with a history of third kidney 161 transplant who presented with vomiting and fever as a first 162 symptom and was finally diagnosed with COVID-19 on 163 follow-up. 164 Laboratory findings revealed that although the majority 165 of COVID-19 patients in the general population have 166 leukopenia and lymphocytopenia (70%) [12], normal white 167 blood cell count was a more frequent finding in our series 168 and leukopenia was detected in one-quarter of our subjects. 169 On admission, lymphocytopenia was detected in 58.33% of 170 our patients, whereas all cases had lymphocytopenia in 171", "latex": null, "type": "figure"}, "FIGREF4": {"text": "to CT images, the most common pattern of 176 lung involvement was bilateral involvement with a diffuse 177 pattern and a posterior segmental distribution. GGO, a 178 feature highly suggestive of COVID-19, was observed in all 179 cases and consolidation in the majority of cases. A crazy-180 paving pattern was observed in two patients, which is 181 consistent with late-phase COVID-19. One-third of our cases 182 had unilateral involvement; in other studies, one case had 183 bilateral GGO [15] and one of five cases described by Zhang 184 et al [13] had unilateral involvement. 185 All the initial CT scan findings were compatible with a 186 normal immune function except for unilateral involvement 187 and consolidation, which were slightly more frequent in our 188 series than in a previous multicenter study of 101 COVIDA 38-yr-old male pati Q1 ent presented with a dry cough and dyspnea and a history of kidney transplantation 15 yr previously. Computed tomography images show bilateral peripheral ground glass opacity (thin arrows) on the anterior side and an area of bilateral consolidation with air bronchogram (wide arrows) on the posterior side, predominantly in the lower lobes. Incidental pneumomediastinum is noted (thick-headed arrows). The patient died after 22 d in hospital.", "latex": null, "type": "figure"}, "FIGREF5": {"text": "A 49-yr-old woman presented with a dry cough, sore throat, headache, and a history of kidney transplantation 17 yr previously. (A,B) Computed tomography (CT) images obtained 3 d after the onset of symptoms show patchy ground-glass opacity in the right inferior lobe with slight central consolidation (long arrows). (C,D) CT images obtained 25 d after the onset of symptoms with secondary superimposed bacterial pneumonia show diffuse bilateral ground-glass opacity and consolidation with air bronchogram (wide arrows) predominantly in the upper lobes and bilateral mild plural effusion (thick-headed arrows). (E,F) CT images obtained 28 d after the onset of symptoms and intravenous antibiotic therapy show evolution of the area of consolidation with vacuolar signs (small black arrows) in the right upper lobe and fibrotic bands (long arrow) in the right lower lobe. The patient was discharged after 37 d.", "latex": null, "type": "figure"}, "FIGREF6": {"text": "multilobar patterns, consolidative lesions, and a high score 198 for lung involvement were more frequent among the 199 patients with poor outcome and complicated cases with 200 ARDS. In addition, all cases with pleural and pericardial 201 effusion or a crazy-paving appearance had poor outcome. 202 Interestingly, two cases had pneumothorax as a rare finding 203 on chest CT at the time of presentation, without any history 204 of intubation or other predisposing procedures. Patients 205 who survived had a shorter hospital stay and a unilateral 206 peripheral pattern limited to only one zone of the lung, with 207 none of the other findings mentioned for patients with poor 208 outcome. 209 In conclusion, CT imaging features may have an 210 important role in predicting COVID-19 outcomes for kidney 211 transplant recipients. However, the majority of the findings 212 are sim Q8 ilar to those from other adult studies for the general 213 population. 214 Conflicts of interest: The authors have nothing to disclose. Q9 215 Appendix A. Supplementary data 216 Supplementary material related to this article can be 217 found, in the online version, at doi:https://doi.org/10.1016/j. 218 eururo.2020.04.064.", "latex": null, "type": "figure"}, "TABREF0": {"text": "There are currently limited", "latex": null, "type": "table"}, "TABREF1": {"text": "Demographic and clinic Q2 al features and outcomes for the 12 patients. KTx = kidney transplantation; CMBs = comorbidities; HTN = hypertension; SA = stable angina; HA = headache; GIS = gastrointestinal symptoms (abdominal pain/ diarrhea); SO 2 = oxygen saturation on room air.", "latex": null, "type": "table"}, "TABREF2": {"text": "Please cite this article in press as: Abrishami A, et al. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients. Eur Urol (2020), https://doi.org/10.1016/j.eururo.2020.04.064 assessed on CT scan images, including interlobular septal thickening, crazy-paving pattern, reverse halo sign, cystic changes, presence of cavitations, lymphadenopathy (defined as lymph node with short axis >10 mm), and pleural 110 and pericardial effusion.", "latex": null, "type": "table"}, "TABREF3": {"text": "Baseline laboratory findings.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>Patient </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>Summary (mean SD)\n</td></tr><tr><td>\u00a0</td><td>1 </td><td>2 </td><td>3 </td><td>4 </td><td>5 </td><td>6 </td><td>7 </td><td>8 </td><td>9 </td><td>10 </td><td>11 </td><td>12 </td><td>\u00a0</td></tr><tr><td>White blood cell count </td><td>2000 </td><td>5500 </td><td>3800 </td><td>5600 </td><td>12200 </td><td>8700 </td><td>7200 </td><td>8800 </td><td>4200 </td><td>3100 </td><td>7500 </td><td>2500 </td><td>59253050\n</td></tr><tr><td>Neutrophil count </td><td>1040 </td><td>4345 </td><td>2470 </td><td>4984 </td><td>11590 </td><td>6264 </td><td>5976 </td><td>7920 </td><td>3318 </td><td>2697 </td><td>6000 </td><td>2050 </td><td>4887.832934.14\n</td></tr><tr><td>Lymphocyte count </td><td>840 </td><td>1100 </td><td>1140 </td><td>560 </td><td>610 </td><td>2001 </td><td>1152 </td><td>704 </td><td>798 </td><td>279 </td><td>1200 </td><td>375 </td><td>896.58464.81\n</td></tr><tr><td>Eosinophils (%) </td><td>3 </td><td>0 </td><td>2 </td><td>0 </td><td>0 </td><td>2 </td><td>0 </td><td>0 </td><td>1 </td><td>2 </td><td>2 </td><td>1 </td><td>-\n</td></tr><tr><td>Hemoglobin (g/dl) </td><td>9.1 </td><td>11.7 </td><td>15.4 </td><td>11 </td><td>9.9 </td><td>12.4 </td><td>9.1 </td><td>11.7 </td><td>13.6 </td><td>11.1 </td><td>15.2 </td><td>8.5 </td><td>11.552.28\n</td></tr><tr><td>Platelets (103) </td><td>131 </td><td>485 </td><td>123 </td><td>148 </td><td>263 </td><td>465 </td><td>160 </td><td>171 </td><td>107 </td><td>54 </td><td>161 </td><td>98 </td><td>197139\n</td></tr><tr><td>C-reactive protein (mg/l) </td><td>17 </td><td>30 </td><td>5 </td><td>61 </td><td>40 </td><td>66 </td><td>24 </td><td>49 </td><td>3 </td><td>31 </td><td>23 </td><td>30 </td><td>31.5819.76\n</td></tr><tr><td>Lactate dehydrogenase (U/l) </td><td>305 </td><td>384 </td><td>412 </td><td>110 </td><td>506 </td><td>80 </td><td>326 </td><td>641 </td><td>592 </td><td>931 </td><td>898 </td><td>928 </td><td>509.41297.36\n</td></tr><tr><td>Creatinine (mg/dl) </td><td>2.99 </td><td>0.92 </td><td>1.53 </td><td>2.55 </td><td>2.96 </td><td>1.77 </td><td>2.50 </td><td>4.60 </td><td>1.23 </td><td>1.50 </td><td>1.51 </td><td>3.60 </td><td>2.31.09\n</td></tr><tr><td>Blood urea nitrogen (mg/dl) </td><td>85 </td><td>23 </td><td>33 </td><td>119 </td><td>156 </td><td>60 </td><td>145 </td><td>150 </td><td>30 </td><td>39 </td><td>18 </td><td>137 </td><td>82.9155.16\n</td></tr><tr><td>Aspartate transaminase (U/l) </td><td>19 </td><td>17 </td><td>25 </td><td>24 </td><td>19 </td><td>26 </td><td>12 </td><td>28 </td><td>37 </td><td>167 </td><td>31 </td><td>12 </td><td>34.7542.3\n</td></tr><tr><td>Alanine transaminase (U/l) </td><td>6 </td><td>11 </td><td>17 </td><td>8 </td><td>19 </td><td>42 </td><td>14 </td><td>14 </td><td>19 </td><td>96 </td><td>43 </td><td>8 </td><td>24.7525.52\n</td></tr><tr><td>Alkaline phosphatase (U/l) </td><td>92 </td><td>118 </td><td>203 </td><td>205 </td><td>128 </td><td>106 </td><td>90 </td><td>102 </td><td>148 </td><td>204 </td><td>237 </td><td>134 </td><td>147.2551.52\n</td></tr><tr><td>Albumin (g/l) </td><td>3.1 </td><td>4 </td><td>3 </td><td>4.5 </td><td>3.1 </td><td>3 </td><td>3.6 </td><td>3.2 </td><td>3.4 </td><td>2.7 </td><td>3.3 </td><td>3.9 </td><td>3.40.51\n</td></tr><tr><td>Na (mEq/l) </td><td>138 </td><td>139 </td><td>138 </td><td>137 </td><td>141 </td><td>143 </td><td>141 </td><td>133 </td><td>137 </td><td>133 </td><td>142 </td><td>140 </td><td>138.53.2\n</td></tr><tr><td>K (mEq/l) </td><td>4.5 </td><td>3.5 </td><td>4.1 </td><td>3.6 </td><td>3.4 </td><td>5 </td><td>5 </td><td>4.1 </td><td>4 </td><td>4.4 </td><td>3.7 </td><td>3.4 </td><td>4.050.57\n</td></tr><tr><td>Prothrombin time (s) </td><td>10.5 </td><td>10.6 </td><td>9.8 </td><td>11.6 </td><td>13.3 </td><td>10 </td><td>11.7 </td><td>11.1 </td><td>9.8 </td><td>14.8 </td><td>9.8 </td><td>9.9 </td><td>11.071.58\n</td></tr><tr><td>Partial thromboplastin time (s) </td><td>20 </td><td>20 </td><td>20 </td><td>22 </td><td>27 </td><td>20 </td><td>23 </td><td>69 </td><td>20 </td><td>37 </td><td>26 </td><td>20 </td><td>27.0514.18\n</td></tr><tr><td>International normalized ratio </td><td>1.01 </td><td>1.06 </td><td>0.9 </td><td>1.13 </td><td>1.3 </td><td>1.1 </td><td>1.14 </td><td>1.07 </td><td>0.94 </td><td>1.4 </td><td>0.9 </td><td>0.95 </td><td>1.070.15\n</td></tr></table></body></html>"}, "TABREF4": {"text": "Frequency of chest computed tomography scan features in the 12 patients.", "latex": null, "type": "table"}, "TABREF5": {"text": "Chest computed tomography scores for each lobe and total lungs.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Lobar anatomy </td><td>Ground glass opacity Consolidation </td><td>Total score\n</td></tr><tr><td>Right upper lobe </td><td>1.5 </td><td>0.16 </td><td>1.66\n</td></tr><tr><td>Right middle lobe </td><td>1.66 </td><td>0 </td><td>1.66\n</td></tr><tr><td>Right lower lobe </td><td>1.41 </td><td>0.91 </td><td>2.32\n</td></tr><tr><td>Left upper lobe </td><td>1.41 </td><td>0.08 </td><td>1.49\n</td></tr><tr><td>Left lower lobe </td><td>1.58 </td><td>0.75 </td><td>2.33\n</td></tr><tr><td>Total lungs </td><td>7.58 </td><td>1.9 </td><td>9.46\n</td></tr></table></body></html>"}, "TABREF6": {"text": "Please cite this article in press as: Abrishami A, et al. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients. Eur Urol (2020), https://doi.org/10.1016/j.eururo.2020.04.064patients[16]. Most patients in the later stages showed subpleural involvement as a less common finding. As the 191 disease progresses, other uncommon findings include pleural/pericardial effusion, lymphadenopathy, cavitation, halo sign, and pneumothorax. The most common imaging features in severely ill patients were bilateral multilobar", "latex": null, "type": "table"}}, "back_matter": []}